JMP Securities Downgrades InterMune Inc. (ITMN) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
Go back to JMP Securities Downgrades InterMune Inc. (ITMN) to Market Perform
August 28, 2014 6:40 AM EDT
UBS downgraded InterMune Inc. (NASDAQ: ITMN) from Buy to Neutral.
For an analyst ratings summary and ratings history on InterMune Inc. click here. For more ratings news on InterMune Inc. click here.
Shares of InterMune Inc. closed at $73.18 yesterday.
...
More
August 26, 2014 6:49 AM EDT
JPMorgan downgraded InterMune Inc. (NASDAQ: ITMN) from Overweight to Neutral with a price target of $74.00.
For an analyst ratings summary and ratings history on InterMune Inc. click here. For more ratings news on InterMune Inc. click here.
Shares of InterMune Inc. closed at $72.85 yesterday.
...
More
August 24, 2014 12:26 PM EDT
As had been rumored the past few weeks, Swiss drug giant Roche (OTC: RHHBY) agreed to acquire InterMune (NASDAQ: ITMN) $74.00 per share in cash, or a 38% premium to Friday's market close. The transaction is worth $8.3 billion on a fully diluted basis.
The merger agreement has been approved by the boards of InterMune and Roche.
Roche will commence a tender offer no later than August 29, 2014, to acquire all outstanding shares of InterMune common stock, and InterMune will... More
